137 related articles for article (PubMed ID: 33795806)
1. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract][Full Text] [Related]
2. LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.
El Ashkar S; Schwaller J; Pieters T; Goossens S; Demeulemeester J; Christ F; Van Belle S; Juge S; Boeckx N; Engelman A; Van Vlierberghe P; Debyser Z; De Rijck J
Blood; 2018 Jan; 131(1):95-107. PubMed ID: 29084774
[TBL] [Abstract][Full Text] [Related]
3. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract][Full Text] [Related]
4. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
[TBL] [Abstract][Full Text] [Related]
5. Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.
Van Belle S; El Ashkar S; Čermáková K; Matthijssens F; Goossens S; Canella A; Hodges CH; Christ F; De Rijck J; Van Vlierberghe P; Veverka V; Debyser Z
Cells; 2021 Jan; 10(1):. PubMed ID: 33477970
[TBL] [Abstract][Full Text] [Related]
6. Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
Sharma S; Čermáková K; De Rijck J; Demeulemeester J; Fábry M; El Ashkar S; Van Belle S; Lepšík M; Tesina P; Duchoslav V; Novák P; Hubálek M; Srb P; Christ F; Řezáčová P; Hodges HC; Debyser Z; Veverka V
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7053-E7062. PubMed ID: 29997176
[TBL] [Abstract][Full Text] [Related]
7. Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75).
Méreau H; De Rijck J; Cermáková K; Kutz A; Juge S; Demeulemeester J; Gijsbers R; Christ F; Debyser Z; Schwaller J
Leukemia; 2013 Jun; 27(6):1245-53. PubMed ID: 23318960
[TBL] [Abstract][Full Text] [Related]
8. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function.
Brouns T; Lux V; Van Belle S; Christ F; Veverka V; Debyser Z
Cells; 2024 Jan; 13(3):. PubMed ID: 38334618
[TBL] [Abstract][Full Text] [Related]
10. High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region.
De Rijck J; Bartholomeeusen K; Ceulemans H; Debyser Z; Gijsbers R
Nucleic Acids Res; 2010 Oct; 38(18):6135-47. PubMed ID: 20484370
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatin.
Hendrix J; van Heertum B; Vanstreels E; Daelemans D; De Rijck J
J Biol Chem; 2014 May; 289(18):12494-506. PubMed ID: 24634210
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract][Full Text] [Related]
13. The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication.
Lopez AP; Kugelman JR; Garcia-Rivera J; Urias E; Salinas SA; Fernandez-Zapico ME; Llano M
J Mol Biol; 2016 Jul; 428(14):2814-31. PubMed ID: 27216501
[TBL] [Abstract][Full Text] [Related]
14. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
[TBL] [Abstract][Full Text] [Related]
15. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
Basu A; Cajigas-Du Ross CK; Rios-Colon L; Mediavilla-Varela M; Daniels-Wells TR; Leoh LS; Rojas H; Banerjee H; Martinez SR; Acevedo-Martinez S; Casiano CA
PLoS One; 2016; 11(1):e0146549. PubMed ID: 26771192
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein and protein-chromatin interactions of LEDGF/p75 as novel drug targets.
Blokken J; De Rijck J; Christ F; Debyser Z
Drug Discov Today Technol; 2017 Jun; 24():25-31. PubMed ID: 29233296
[TBL] [Abstract][Full Text] [Related]
17. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity.
Leoh LS; van Heertum B; De Rijck J; Filippova M; Rios-Colon L; Basu A; Martinez SR; Tungteakkhun SS; Filippov V; Christ F; De Leon M; Debyser Z; Casiano CA
Mol Cancer Res; 2012 Mar; 10(3):378-91. PubMed ID: 22275515
[TBL] [Abstract][Full Text] [Related]
18. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes.
Llano M; Vanegas M; Fregoso O; Saenz D; Chung S; Peretz M; Poeschla EM
J Virol; 2004 Sep; 78(17):9524-37. PubMed ID: 15308744
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
[TBL] [Abstract][Full Text] [Related]
20. Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells.
Basu A; Drame A; Muñoz R; Gijsbers R; Debyser Z; De Leon M; Casiano CA
Prostate; 2012 May; 72(6):597-611. PubMed ID: 21796653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
